OLAnzaPiNE

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

November, 2024

OLAnzaPiNE

Oct 2, 2024, 14:53 | Blog

Eric Singhi: An opportunity to improve patient education

Eric Singhi shared a post on X: "I'm a big advocate for olanzapine and its…

Aug 14, 2024, 07:33 | Insight

Olanzapine as antiemetic prophylaxis in chemotherapy

Elisa Agostinetto shared on X: "Olanzapine as antiemetic prophylaxis in chemotherapy. In this randomized phase…

Aug 12, 2024, 06:05 | Insight

Results suggest olanzapine should be a standard to reduce chemotherapy-induced nausea and vomiting

Kenrick Ng, Consultant in Medical Oncology at Barts Health NHS Trust shared a post on…

Jul 21, 2024, 21:49 | Blog

Mark Lewis: Consider Olanzapine for chemotherapy-induced nausea/vomiting

Mark Lewis posted on X/Twitter about a recent paper by Jyoti Bajpai et al., commenting: "I…

Dec 16, 2023, 18:18 | Insight

SABCS23 Day 2 Highlights by Oncology Brothers

Oncology Brothers have recently shared their highlights from SABCS23. Below we feature the second day's…

All: 5 Posts: 1 - 100

Dr. Richard Pazdur: 25 Years of Transforming Oncology Drug Development at the FDA

New €4.9m Beaumont RCSI Cancer Centre and Irish Cancer Society Partnership to Transform Lung Cancer Care in Ireland

Biden Cancer Moonshot Initiative Awards Over $6 Million to 11 Early-Career Researchers for Innovative Cancer Research

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Special Coverage

ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023